These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 14083462)

  • 21. Committee on the Review of Medicines. Recommendations on phenylbutazone, oxyphenbutazone, feprazone, allopurinol, colchicine, probenecid, and sulphinpyrazone.
    Br Med J; 1978 Jun; 1(6125):1466-7. PubMed ID: 306273
    [No Abstract]   [Full Text] [Related]  

  • 22. Pyrazolidines in the treatment of gout.
    Kuzell WC
    Can Med Assoc J; 1968 Nov; 99(21):1038-43. PubMed ID: 5721943
    [No Abstract]   [Full Text] [Related]  

  • 23. [TREATMENT OF GOUT].
    RUFFIE R; FOURNIE A
    Clinique (Paris); 1964 Jan; 59():7-11. PubMed ID: 14133633
    [No Abstract]   [Full Text] [Related]  

  • 24. [NEPHROPATHIES AND RENAL LITHIASIS IN GOUT PATIENTS (OLD AND NEW PROBLEMS)].
    FOGLIERINI J
    Rhumatologie; 1963; 15():111-22. PubMed ID: 14186441
    [No Abstract]   [Full Text] [Related]  

  • 25. GOUT IN THE ELDERLY. MODERN MANAGEMENT IN HISTORICAL PERSPECTIVE.
    MCCORMICK EW
    Geriatrics; 1965 Sep; 20():756-8. PubMed ID: 14333673
    [No Abstract]   [Full Text] [Related]  

  • 26. Uricosuric agents.
    Fanelli GM
    Arthritis Rheum; 1975; 18(6 Suppl):853-8. PubMed ID: 1201130
    [No Abstract]   [Full Text] [Related]  

  • 27. Management of gout.
    Gordon GV; Schumacher HR
    Am Fam Physician; 1979 Jan; 19(1):91-7. PubMed ID: 760433
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Antarthritics. 41].
    Mayr E
    Pharm Prax; 1969 Dec; 12():267-9. PubMed ID: 4909745
    [No Abstract]   [Full Text] [Related]  

  • 29. Drugs for gout.
    Med Lett Drugs Ther; 1976 Jun; 18(12):49-51. PubMed ID: 934016
    [No Abstract]   [Full Text] [Related]  

  • 30. [Clinical aspects of gout, based on personal observation of 40 cases].
    OSHIMA Y; YOSHIMURA T; SATO T; KAGAMI T; AKAOKA I; NISHIZAWA T
    Naika; 1962 Jun; 11():1244-56. PubMed ID: 13940531
    [No Abstract]   [Full Text] [Related]  

  • 31. Treatment of gout.
    Goldfinger SE
    N Engl J Med; 1971 Dec; 285(23):1303-6. PubMed ID: 4941493
    [No Abstract]   [Full Text] [Related]  

  • 32. Drug control of gout and hyperuricaemia.
    Emmerson BT
    Drugs; 1978 Aug; 16(2):158-66. PubMed ID: 352666
    [No Abstract]   [Full Text] [Related]  

  • 33. The management of gout.
    McCarty DJ
    Hosp Pract; 1979 Sep; 14(9):75-8, 83-5. PubMed ID: 478531
    [No Abstract]   [Full Text] [Related]  

  • 34. Gout.
    FREYBERG RH
    Arthritis Rheum; 1962 Dec; 5():624-33. PubMed ID: 13959652
    [No Abstract]   [Full Text] [Related]  

  • 35. BIOCHEMICAL PROPERTIES OF ANTI-INFLAMMATORY DRUGS-II. SOME EFFECTS ON SULPHATE-35S METABOLISM IN VIVO.
    BOSTROEM H; BERNTSEN K; WHITEHOUSE MW
    Biochem Pharmacol; 1964 Mar; 13():413-20. PubMed ID: 14157603
    [No Abstract]   [Full Text] [Related]  

  • 36. [CASE OF CHRONIC TOPHOCEOUS GOUT].
    ITO H; OKAZAKI M; AKAOKA I; KOYAMA S
    Iryo; 1963 Dec; 17():736-40. PubMed ID: 14123823
    [No Abstract]   [Full Text] [Related]  

  • 37. Uricosuric drugs, with special reference to probenecid and sulfinpyrazone.
    Gutman AB
    Adv Pharmacol (1962); 1966; 4():91-142. PubMed ID: 5333771
    [No Abstract]   [Full Text] [Related]  

  • 38. [Gout from the view of a special hospital for rheumatic patients].
    Klotz H; Prohaska E; Salmhofer H; Schmid L
    Wien Klin Wochenschr; 1971 Mar; 83(11):177-80. PubMed ID: 5314855
    [No Abstract]   [Full Text] [Related]  

  • 39. [The treatment of osteoarticular gout. (Reflections apropos of 230 personal cases)].
    SERRE H; SIMON L
    Rhumatologie; 1962; 14():115-20. PubMed ID: 13988144
    [No Abstract]   [Full Text] [Related]  

  • 40. Therapy of gout.
    Gaines LM
    Johns Hopkins Med J; 1967 Nov; 121(5):361-4. PubMed ID: 6075623
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.